Run Lin
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Nanoparticle-Based Drug Delivery 7
-
- Central Venous Catheters and Hemodialysis 5
- Co-authors
- Weiling He (8 shared papers)Jin-zhi Du (4 shared papers)Jing H. Huang (6 shared papers)Jun Wang (2 shared papers)Hui Z. Mao (6 shared papers)Hongjun Li (1 shared paper)Lily P H Yang (4 shared papers)Zunfu Ke (3 shared papers)
- Journals
- Biomaterials Science (2 papers)Journal of Materials Chemistry B (2 papers)Pharmaceuticals (1 paper)IEEE Transactions on Neural Networks and Learning Systems (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Run Lin
32 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 92
- Biomaterials 402
- Oncology 356
- Drug Discovery 4
- Pharmaceutical Science 87
- Immunology 170
Countries citing papers authored by Run Lin
This map shows the geographic impact of Run Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Run Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Run Lin more than expected).
Fields of papers citing papers by Run Lin
This network shows the impact of papers produced by Run Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Run Lin. The network helps show where Run Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Run Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 280 | |
| 2 | 2018 | 247 | |
| 3 | 2020 | 195 | |
| 4 | 2013 | 149 | |
| 5 | 2020 | 91 | |
| 6 | 2021 | 69 | |
| 7 | 2017 | 63 | |
| 8 | 2015 | 57 | |
| 9 | 2019 | 56 | |
| 10 | 2016 | 44 | |
| 11 | 2022 | 40 | |
| 12 | 2018 | 36 | |
| 13 | 2024 | 31 | |
| 14 | 2023 | 30 | |
| 15 | 2021 | 28 | |
| 16 | 2013 | 27 | |
| 17 | 2021 | 25 | |
| 18 | 2024 | 24 | |
| 19 | 2020 | 23 | |
| 20 | 2023 | 12 |
About Run Lin
Run Lin is a scholar working on Biomaterials, Emergency Medical Services, Hepatology, Biomedical Engineering and Oncology, having authored 33 papers that have together received 1.6k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Central Venous Catheters and Hemodialysis (5 papers), Characterization and Applications of Magnetic Nanoparticles (5 papers), Nanoplatforms for cancer theranostics (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Hydrogels: synthesis, properties, applications (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Biomaterials (402 citations), Oncology (356 citations), Drug Discovery (4 citations), Pharmaceutical Science (87 citations) and Immunology (170 citations). Run Lin has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Weiling He, Jin-zhi Du, Jing H. Huang, Jun Wang, Hui Z. Mao, Hongjun Li, Lily P H Yang, Zunfu Ke, Hui Zhang and Yonghui Huang. Their work appears in journals such as Biomaterials Science, Journal of Materials Chemistry B, Pharmaceuticals, IEEE Transactions on Neural Networks and Learning Systems and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.